Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
Note
If you intend to rely on any legislation referred to on this website, you should access copies of the official versions on the Attorney General's Department's Federal Register of Legislation website.
Section 16(1) and (1A) of the Therapeutic Goods Act 1989 list the differences that result in goods being considered separate and distinct from other goods.
Some therapeutic goods are considered to be in a 'gazetted therapeutic goods group'. Gazetted therapeutic goods groups are determined by orders published in the Gazette.
However, individual products within the group remain separate and distinct products under section 16(1) and (1A).